ADA Wants Firms to Disclose Incretin Data

(MedPage Today) -- The American Diabetes Association is calling for makers of incretin therapies to release all of their data on the drugs in an effort to clarify whether they have adverse effects on the pancreas, the group said.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news